Get started
Author

C Y Huang

Observed names: Chiung-Yu Huang, Chiung‐Yu Huang
OpenAlex ID: A5136376180
Real‐World Evaluation of Talquetamab for the Treatment of Relapsed/Refractory Multiple Myeloma ( RRMM ): An International Myeloma Working Group Immunotherapy Registry Real‐World Analysis
2026 · Murali Janakiram, Carlyn R. Tan, et al. · American Journal of Hematology · 2
How long is long enough? Outcomes with finite-duration bispecific antibody therapy in multiple myeloma.
2026 · Eva Duvalyan, Jihong Song, et al. · Journal of Clinical Oncology · 1
A phase 2 study of olutasidenib in combination with azacitidine followed by olutasidenib maintenance after venetoclax plus a hypomethylating agent regimen for IDH1 -mutated acute myeloid leukemia (University of California Hematologic Malignancies Consortium Study 2441).
2026 · Brian Andrew Jonas, Mohammad Bukari, et al. · Journal of Clinical Oncology
C47-31 A Refined Lung Transplant Frailty Scale Incorporating Serum Albumin Is Associated With Risk of Mortality in Lung Transplant Candidates
2026 · A Sriram, J D Christie, et al. · American Journal of Respiratory and Critical Care Medicine
PDF
Works count: 4
Citation count: 3
H-index: 1
I10-index:
Year
Topic
Type